Skip to main content
Clinical Trials/CTRI/2024/01/061125
CTRI/2024/01/061125Not yet recruitingPhase 2

A Comparative Interventional Study to assess the efficacy of Intravenous Ketamine versus Oral Ketamine for patients with suicidal ideation - NI

A0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor
A

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1. Subjects aged 18 to 65 years with suicidal ideation having HAMD score more than or equal to 14 and Beck
  • suicidal ideation scale of more than or equal to 5
  • 2. Subjects willing to take Ketamine after informed written consent.

Exclusion Criteria

  • 1. Contraindication to the administration of ketamine, especially present diagnosis or
  • antecedents of clinically relevant cardiovascular disorders such as stroke, heart attack,
  • 2. If they had any, those with present or past diagnosis of glaucoma, intracranial
  • hypertension.
  • 3. Current diagnosis of schizophrenia or other psychotic disorder (including psychotic
  • disorder due to general medical condition, substance-induced psychotic disorder, or
  • mania) as defined in the ICD-11
  • 4. Patients with any known hypersensitivity to ketamine.
  • 5. Subjects having any substance dependence, intoxication or withdrawal within 1
  • month period

Investigators

Sponsor
A

Similar Trials

A study comparing the effectiveness of... | Clinical Trial